Loading organizations...
§ Private Profile · Wellesley, MA, USA
Provides cloud-based RTSM software and clinical supply optimization for the life sciences industry, accelerating clinical trials.
4G Clinical is a Wellesley, Massachusetts-based software company that provides cloud-based Randomization and Trial Supply Management (RTSM) and clinical supply optimization solutions for the life sciences industry. The company's platform utilizes natural language processing to automate trial design and streamline the drug supply chain for pharmaceutical and biotechnology companies. Operating globally with over 300 employees, the firm's software has been deployed across approximately 250 concurrent clinical studies targeting various therapeutic areas. Within the clinical trial technology sector, 4G Clinical competes with legacy software providers including Medidata, Parexel, and Bioclinica. In 2021, the enterprise secured a $230 million growth equity investment led by Goldman Sachs Asset Management to fund its expansion into the Asia Pacific and European markets. 4G Clinical was founded in 2015 by David Kelleher and Ed Tourtellotte.
4G Clinical has raised $237.5M across 3 funding rounds.
4G Clinical has raised $237.5M in total across 3 funding rounds.
4G Clinical has raised $237.5M across 3 funding rounds. Most recently, it raised $230.0M Other Equity in June 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 4, 2021 | $230M Venture Round | Jason Kreuziger, CFA | — | Announced |
| Oct 4, 2016 | $5M Series A | TED Henderson | — | Announced |
| Jan 4, 2016 | $2.5M Series A | Schooner Capital | — | Announced |
4G Clinical has raised $237.5M in total across 3 funding rounds.
4G Clinical's investors include Jason Kreuziger, CFA, Ted Henderson, Schooner Capital.